Integrating -omics approaches into population-based studies of endocrine disrupting chemicals: a scoping review

Abstract

Health effects of endocrine disrupting chemicals (EDCs) are challenging to detect in the general population. Omics technologies become increasingly common to identify early biological changes before the apparition of clinical symptoms, to explore toxic mechanisms and to increase biological plausibility of epidemiological associations. This scoping review systematically summarises the application of omics in epidemiological studies assessing EDCs-associated biological effects to identify potential gaps and priorities for future research. Ninety-eight human studies (2004–2021) were identified through database searches (PubMed, Scopus) and citation chaining and focused on phthalates (34 studies), phenols (19) and PFASs (17), while PAHs (12) and recently-used pesticides (3) were less studied. The sample sizes ranged from 10 to 12,476 (median = 159), involving non-pregnant adults (38), pregnant women (11), children/adolescents (15) or both populations studied together (23). Several studies included occupational workers (10) and/or highly exposed groups (11) focusing on PAHs, PFASs and pesticides, while studies on phenols and phthalates were performed in the general population only. Analysed omics layers included metabolic profiles (30, including 14 targeted analyses), miRNA (13), gene expression (11), DNA methylation (8), microbiome (5) and proteins (3). Twenty-one studies implemented targeted multi-assays focusing on clinical routine blood lipid traits, oxidative stress or hormones. Overall, DNA methylation and gene expression associations with EDCs did not overlap across studies, while some EDC-associated metabolite groups, such as carnitines, nucleotides and amino acids in untargeted metabolomic studies, and oxidative stress markers through targeted studies were consistent across studies. Studies had common limitations such as small sample sizes, cross-sectional designs and single sampling for exposure biomonitoring. In conclusion, there is a growing body of evidence evaluating the early biological responses to exposure to EDCs. This review points to a need for larger longitudinal studies, wider coverage of exposures and biomarkers, replication studies and standardisation of research methods and reporting.

Southeast Asia’s environmental challenges: emergence of new contaminants and advancements in testing methods

“…These approaches offer a holistic view of the response of biological systems to chemical exposure, provide a deeper understanding of the complex mechanisms of toxicity and potential risks posed by chemicals, reveal dynamic cellular responses, and pave the way for a more comprehensive understanding of the effects of chemical agents on biological systems. Several studies have investigated the effects of PFAS ( Yao et al, 2019 ; Beale et al, 2022 ), pharmaceuticals ( Collins et al, 2007 ; Yan et al, 2015 ), pesticides ( Manfei et al, 2019 ; Goh et al, 2021 ), and EDCs ( Messerlian et al, 2017 ; Sharma et al, 2022 ; Maitre et al, 2023 ).…”

Comprehensive mapping of the AOP-Wiki database: identifying biological and disease gaps

“…NAMs are developed to identify a toxicologically relevant response at different biological levels (molecular, cellular, organ, organism) provoked by a chemical exposure (Vinken et al, 2017). NAMs include in cellulo, in vitro and in chemico screening, computational methods as well as high throughput multi-omics and exposomics (Babin et al, 2023;Maitre et al, 2023) to mention but a few methodologies. Recently, a study explored the progress in this 'next-generation' of risk assessment methodologies, and highlighted a low, but still growing evolution and use of NAMs in toxicity testing and risk assessment (Krewski et al, 2020).…”